Abstract Guidelines

Submission of an abstract for ESCMID Global 2024 (formerly known as ECCMID) indicates your consent for inclusion of the abstract in the congress materials (electronic and in print). The submitted abstract should be based on novel data not previously presented or published. The ESCMID Global 2024 Programme Committee reserves the right to reject an abstract or deny the presentation of abstract materials at ESCMID Global 2024 if the data have been published in an international journal, earlier than six weeks before the congress.

If the scientific work has been submitted for publication, accepted, and published in a scientific journal between the ESCMID Global 2024 abstract submission deadline and the congress, we expect authors to ensure that data presented during the congress are updated or feature new perspectives to avoid redundancies and duplications of already published information.

NOTE: This rule does not apply to posted pre-prints.

Before submitting the abstract to ESCMID Global 2024, please read the guide explaining step-by-step how to navigate the submission process. If you do not find the answer to your specific question regarding submission, please contact us at eccmidabstracts[at]escmid.org.

Abstracts should fall into one of two selectable categories:

1. Regular abstract
2. Case report/series

If ‘Case report/ series’ is selected, the template sections:

Background/Materials/Results/Conclusions will be automatically replaced by:

Background/Case(s) description/Discussion

Please ensure that all author names are correct upon submission. It is the responsibility of the presenting author to ensure that this is kept up to date in case of changes.

If the submitter is a co-author of the abstract, we kindly ask them to include their information on the author list, as this does not take place automatically.

Please check the correct spelling and formatting of the author(s) names and affiliation(s).

Please use appropriate capitalisation and punctuation.

ESCMID takes no responsibility for errors in either author or affiliation information.

ALL CAPS for text (other than abbreviations or acronyms) are not allowed. The text of the entire abstract including the title must not exceed 350 words (excluding figure descriptions and references). Use British English spelling.

The abstract title should be concise and submitted in line with scientific rules. This applies to special characters and words that must be CAPITALISED or italicised.

• Please DO NOT capitalise the title except the first word
• Please DO NOT use a dot to finish the title
• Please DO NOT use any brand names in the title

ESCMID reserves the right to proofread and adjust titles according to ECCMID guidelines format without the consent of the author.

Use the provided fields to draft your abstract. Please ensure that different sections of your abstract are entered into the appropriate textbox. For research abstracts, briefly state the background, context of research, and its goals.

The methods section should provide the minimum required information on the research setting, data collection, and analytical methods.

The results presented in the abstract should be original, not published or presented previously.

For Case report/series and CGR cases (usually featuring a single illustrative case or a series of up to 10 cases), emphasise the unique aspects of the case (e.g. with respect to clinical presentation, diagnosis or treatment) and discuss the learning points emerging from the case(s).

Narrative reviews or abstracts without genuine data content cannot be accepted.

Please use the figure upload fields at the bottom to select up to three images. Figure sections can be used to upload images, graphs, or tables.

Accepted formats: JPEG or PNG. Size: 1000x1000 pixels max. File size: up to 5 MB. Images larger than the provided dimensions will be automatically resized to an A4 format in your submission confirmation.

Please check the readability of uploaded materials before submitting your abstract.

Use British English spelling throughout. The International System of Units (SI) should be used wherever appropriate. Genus and species names should be written in full as mentioned first and abbreviated subsequently. Italicise when appropriate.

The following scientific rules apply (examples in brackets):

• Systematic names (genus, family, and higher orders): capitalised (e.g., Chlamydia, Enterobacterales Picornaviridae)
• Non-English expressions in English texts are written in italics (e.g., in vitro/in vivo, ad hoc, ex officio)
• Taxonomic names must be italicised (e.g., Staphylococcus aureus, Clostridium difficile)
• Non-systematic names (e.g., plural): lowercase and not italicised (group A streptococci, mycobacteria)
• Generic drug names: lowercase (e.g., penicillin)
• Do not use brand names in titles: product names are allowed in the abstract text, but must be avoided in the title
• Please follow standard English grammar rules, including a space after full stops and commas
• Only common abbreviations may be used without definition

The full list of abstract topics may be found here.

Please choose the best-fitting abstract category and sub-category to ensure allocation for review by the most suitable reviewing experts and best fit to the session in case of acceptance.

All case and case series abstracts will be automatically assigned to category 12. Case reports and case series (n<10).

Authors are asked to choose two keywords from the dropdown and one free keyword to define the best abstract content.

You can save your abstract at any time. Please make sure to fill all fields correctly before final submission. Changes in the abstract are not possible after submission. After submission, an email confirmation will be sent to the submitter (please state your correct email address!). All co-authors will be notified by email and receive a copy of the submitted abstract. The submitter is responsible for obtaining permission for submission and presentation of the abstract from all co-authors and any relevant stakeholders. All correspondence regarding acceptance or rejection, including further information on the mode of presentation, etc., will be sent to the presenting author.

If an abstract is not accepted for an oral presentation, it may be accepted as a poster presentation, and the presenting authors will receive notification via email. 

Should you decide to change the type of abstract once you have started the submission, please withdraw your current abstract and re-start the submission process with new content.

Following ESCMID Global (formerly known as ECCMID), a certificate of presentation will be available to the presenting authors at cme.eccmid.org. The presenting author is then responsible for disseminating this certificate to co-authors.

If you have any questions or need assistance, please do not hesitate to contact us at eccmidabstracts[at]escmid.org.